Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ardelyx Share Holder Equity 2013-2025 | ARDX

Ardelyx share holder equity from 2013 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
  
Ardelyx Annual Share Holder Equity
(Millions of US $)
2024 $173
2023 $167
2022 $98
2021 $83
2020 $126
2019 $187
2018 $116
2017 $139
2016 $193
2015 $109
2014 $61
2013 $-7
2012 $-1
Ardelyx Quarterly Share Holder Equity
(Millions of US $)
2025-03-31 $146
2024-12-31 $173
2024-09-30 $158
2024-06-30 $147
2024-03-31 $151
2023-12-31 $167
2023-09-30 $191
2023-06-30 $123
2023-03-31 $125
2022-12-31 $98
2022-09-30 $67
2022-06-30 $53
2022-03-31 $64
2021-12-31 $83
2021-09-30 $81
2021-06-30 $118
2021-03-31 $131
2020-12-31 $126
2020-09-30 $131
2020-06-30 $146
2020-03-31 $168
2019-12-31 $187
2019-09-30 $49
2019-06-30 $69
2019-03-31 $92
2018-12-31 $116
2018-09-30 $141
2018-06-30 $163
2018-03-31 $129
2017-12-31 $139
2017-09-30 $127
2017-06-30 $145
2017-03-31 $168
2016-12-31 $193
2016-09-30 $223
2016-06-30 $141
2016-03-31 $168
2015-12-31 $109
2015-09-30 $125
2015-06-30 $142
2015-03-31 $58
2014-12-31 $61
2014-09-30 $63
2014-06-30 $63
2014-03-31 $-10
2013-12-31 $-7
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $-1
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.890B $0.334B
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.521B 32.46
Zoetis (ZTS) United States $75.160B 28.04
Takeda Pharmaceutical (TAK) Japan $48.970B 9.74
Daiichi Sankyo, - (DSNKY) Japan $47.728B 24.46
BeOne Medicines - (ONC) Cayman Islands $30.278B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.478B 0.00
Merck (MKKGY) Germany $17.344B 12.71
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.530B 14.56
United Therapeutics (UTHR) United States $12.907B 11.42
Neurocrine Biosciences (NBIX) United States $12.372B 42.38
Orion OYJ (ORINY) Finland $10.289B 27.82
IPSEN (IPSEY) France $9.940B 0.00
Corcept Therapeutics (CORT) United States $7.548B 61.36
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.599B 0.00
Grifols, S.A (GRFS) Spain $6.174B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.669B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.042B 0.00
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.012B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.963B 10.38
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
NewAmsterdam Pharma (NAMS) Netherlands $2.361B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.176B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.102B 0.00
Indivior (INDV) United States $1.921B 8.15
Dyne Therapeutics (DYN) United States $1.644B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.608B 0.00
Evotec AG (EVO) Germany $1.577B 0.00
Ocular Therapeutix (OCUL) United States $1.426B 0.00
ARS Pharmaceuticals (SPRY) United States $1.414B 0.00
Guardian Pharmacy Services (GRDN) United States $1.282B 0.00
Harrow (HROW) United States $1.143B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.112B 22.24
Enliven Therapeutics (ELVN) United States $0.965B 0.00
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Avadel Pharmaceuticals (AVDL) Ireland $0.904B 0.00
Cronos Group (CRON) Canada $0.768B 0.00
Elite Pharmaceuticals (ELTP) United States $0.735B 0.00
Xeris Biopharma Holdings (XERS) United States $0.691B 0.00
Xencor (XNCR) United States $0.671B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Relay Therapeutics (RLAY) United States $0.591B 0.00
AleAnna (ANNA) United States $0.586B 0.00
Altimmune (ALT) United States $0.580B 0.00
Verve Therapeutics (VERV) United States $0.563B 0.00
Regulus Therapeutics (RGLS) United States $0.559B 0.00
USANA Health Sciences (USNA) United States $0.555B 12.06
Bioventus (BVS) United States $0.551B 13.98
Theravance Biopharma (TBPH) United States $0.531B 0.00
Liminatus Pharma (LIMN) United States $0.528B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
Tourmaline Bio (TRML) United States $0.511B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.482B 0.00
Siga Technologies (SIGA) United States $0.460B 9.61
Organogenesis (ORGO) United States $0.402B 0.00
Savara (SVRA) United States $0.391B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 10.29
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Heron Therapeutics (HRTX) United States $0.307B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.49
ProKidney (PROK) United States $0.262B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.238B 0.00
MediWound (MDWD) Israel $0.220B 0.00
OmniAb (OABI) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Larimar Therapeutics (LRMR) United States $0.186B 0.00
Aldeyra Therapeutics (ALDX) United States $0.175B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.136B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.109B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.108B 0.00
Fractyl Health (GUTS) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
Champions Oncology (CSBR) United States $0.102B 16.81
Wellgistics Health (WGRX) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 65.11
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.085B 0.00
Nutriband (NTRB) United States $0.085B 0.00
Inotiv (NOTV) United States $0.081B 0.00
Surrozen (SRZN) United States $0.080B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Klotho Neurosciences (KLTO) United States $0.065B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
China SXT Pharmaceuticals (SXTC) China $0.032B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
BioVie (BIVI) United States $0.022B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00